Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...

Talk about a breath of fresh air. Researchers have developed a groundbreaking device that may one day make detecting lung cancer as easy as exhaling. “We built a screening tool that could allow ...

A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...

BEIJING, 4 February (BelTA - China Daily) - A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including ...

Lung cancer is one of the major causes of cancer-related fatalities in the global society, particularly due to its late diagnosis in most cases. Early diagnosis has great benefits in terms of survival ...

The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine ...